Matches in Wikidata for { <http://www.wikidata.org/entity/Q73122171> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q73122171 description "artículu científicu espublizáu n'ochobre de 2000" @default.
- Q73122171 description "im Oktober 2000 veröffentlichter wissenschaftlicher Artikel" @default.
- Q73122171 description "scientific article published on 01 October 2000" @default.
- Q73122171 description "wetenschappelijk artikel" @default.
- Q73122171 description "наукова стаття, опублікована в жовтні 2000" @default.
- Q73122171 name "Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group" @default.
- Q73122171 name "Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group" @default.
- Q73122171 type Item @default.
- Q73122171 label "Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group" @default.
- Q73122171 label "Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group" @default.
- Q73122171 prefLabel "Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group" @default.
- Q73122171 prefLabel "Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group" @default.
- Q73122171 P1433 Q73122171-636A9FD8-C7F5-4684-9A8F-3A87DD7BD624 @default.
- Q73122171 P1476 Q73122171-27DC4587-8BA8-4CE8-8825-0DA357543030 @default.
- Q73122171 P2093 Q73122171-5901C4EB-2E33-4C7E-9560-CF5645CEBE9B @default.
- Q73122171 P2093 Q73122171-65C96D8D-466D-4085-A57E-B27AECA3C1C9 @default.
- Q73122171 P304 Q73122171-65183B1F-5ED6-47FB-995B-8E4A61633C2A @default.
- Q73122171 P31 Q73122171-E919AF4E-111E-4B39-A216-CEF9AD6F97BA @default.
- Q73122171 P356 Q73122171-108DAF6F-41B0-499F-9834-15DFF4BBA3BC @default.
- Q73122171 P433 Q73122171-B2BC3E10-A60E-426B-A0EB-671DC523F705 @default.
- Q73122171 P478 Q73122171-ABA1CE27-EBB7-43C2-9E28-2986466BF195 @default.
- Q73122171 P577 Q73122171-07CE261C-CA7E-4D2E-B3BC-FE523444FDAD @default.
- Q73122171 P698 Q73122171-0DB9F931-3508-4D08-811A-AD38027EE8A9 @default.
- Q73122171 P921 Q73122171-BB59EB9A-8734-41DC-B604-81B116EA1026 @default.
- Q73122171 P356 J.1528-1157.2000.TB04605.X @default.
- Q73122171 P698 11051122 @default.
- Q73122171 P1433 Q5382969 @default.
- Q73122171 P1476 "Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group" @default.
- Q73122171 P2093 "E Ben-Menachem" @default.
- Q73122171 P2093 "U Falter" @default.
- Q73122171 P304 "1276-1283" @default.
- Q73122171 P31 Q13442814 @default.
- Q73122171 P356 "10.1111/J.1528-1157.2000.TB04605.X" @default.
- Q73122171 P433 "10" @default.
- Q73122171 P478 "41" @default.
- Q73122171 P577 "2000-10-01T00:00:00Z" @default.
- Q73122171 P698 "11051122" @default.
- Q73122171 P921 Q417227 @default.